Unspecified vulnerability in Oracle Pharmaceutical Applications 4.5.1 has unknown impact and remote authenticated attack vectors, aka Vuln# PHAR01.
Conclusion & alert: CVE-2006-5374 is rated High Risk (71.5/100): CVSS Critical severity, with medium exploitation likelihood (EPSS 3.35%). Core evidence: EPSS rose +1.06% over the last day, indicating growing attacker interest. Mandatory action: High exploitation likelihood—assess exposure and prioritize remediation.
Risk is dynamic; we continuously reassess and refresh what is shown on this page as upstream context changes.
EPSS lead: Daily EPSS estimates relative likelihood of exploitation; percentile ranks this CVE among scored vulnerabilities (higher = more severe relative rank).
| # | Date | Old EPSS score | New EPSS score | Delta (New - Old) |
|---|---|---|---|---|
| 1 | 2026-06-15 | 2.28% | 3.35% | +1.06% |
| 2 | 2025-09-20 | 2.75% | 2.28% | -0.47% |
| 3 | 2025-06-06 | — | 2.75% | — |
Full EPSS history (15 records total)
CVSS metrics for this CVE.
| Base score | Version | Severity | Vector | Exploitability | Impact | Score source |
|---|---|---|---|---|---|---|
| 10.0 | 2.0 | HIGH |
|
10.0 | 10.0 | [email protected] |
| vendor | priority | summary | link |
|---|---|---|---|
alpine
|
— | CVE-2006-5374: no source package rows; 0 state rows across 0 repos (none); fixed 0, open 0. | https://security.alpinelinux.org/vuln/CVE-2006-5374 |
| Vendor | Product | Version | Raw CPE |
|---|---|---|---|
| oracle | pharmaceutical | 4.5.1 | cpe:2.3:a:oracle:pharmaceutical:4.5.1:*:*:*:*:*:*:* |